Showing 2081-2090 of 3139 results for "".
- MTI/ASPS Plastic Surgery Accelerator Propels Five Plastic Surgery Startups to Final Round of Medtech Competitionhttps://modernaesthetics.com/news/mtiasps-plastic-surgery-accelerator-propels-five-plastic-surgery-startups-to-final-round-of-medtech-competition/2473430/Five plastic surgery startups made it to the finals of MedTech Innovator (MTI)/ American Society of Plastic Surgeons (ASPS) accelerator track in the 2023 MedTech Innovator Accelerator program and competition. The plastic surgery track startups selected to advance include: <
- Xeomin Performs Well in Phase 3 Studies of Upper Facial Lineshttps://modernaesthetics.com/news/xeomin-performs-well-in-phase-3-studies-of-upper-facial-lines/2473428/Two pivotal phase 3 clinical studies demonstrated the efficacy and safety of Xeomin (incobotulinumtoxinA) in the simultaneous treatment of horizontal forehead lines, glabellar frown lines, and lateral canthal lines, according to Merz Aesthetics. Merz Aesthetics will submit these data as
- Botox Cosmetic Announces the Winners of the IFundWomen Grant Programhttps://modernaesthetics.com/news/botox-cosmetic-announces-the-winners-of-the-ifundwomen-grant-program/2473427/Twenty female entrepreneurs will receive funding and mentorship through Allergan’s BOTOX Cosmetic and IFundWomen grant program. "There were so many remarkable applications that featured thoughtful business solutions," says Carrie Strom, President, Global Aller
- Microneedling Plus Cupping May Aid Skin Rejuvenationhttps://modernaesthetics.com/news/microneedling-plus-cupping-may-aid-skin-rejuvenation/2473420/Microneedling to induce collagen and cupping to increase tissue perfusion may have a synergistic effect on skin rejuvenation, according to an experimental study in the June issue of Plastic and Reconstructive Surgery. "Cupping therapy can be added to microneedling therap
- Cutera Update: Agreements Made with Pura Vida and RTW; New Board Members Appointedhttps://modernaesthetics.com/news/cutera-update-agreements-with-pura-vida-and-rtw/2473414/Cutera announced that it has entered into cooperation agreements with two of its largest stockholders, Pura Vida Investments LLC and RTW Investments LP, which collectively own more than 15% of the company’s outstanding shares. Pursuant to the agreements, Cutera will appo
- Analysis: Millennials Drive Spending Growth in a Post-COVID Aesthetics Industryhttps://modernaesthetics.com/news/analysis-millennials-drive-spending-growth-in-a-post-covid-aesthetics-industry/2473413/The aesthetics industry is undergoing a swift transformation. Analysis of data from the last 5 years paints a clear picture of a post-pandemic shift in how the industry is addressing changing demand and the needs of a rapidly evolving customer base, according to market intelligence prov
- Study Shows Preventive Effects and Protective Potential of Astaxanthin on Collagen Damagehttps://modernaesthetics.com/news/study-shows-preventive-effects-and-protective-potential-of-astaxanthin-on-collagen-damage/2473411/A study recently found that Lycored's astaxanthin prevented against collagen damage from neutrophils, discovering its potential to protect collagen and enhance skin health. The study,
- MD360 Introduces Silkro RF Microneedling Platform with Plasmahttps://modernaesthetics.com/news/md360-introduces-silkro-rf-microneedling-platform-with-plasma/2473410/MD360 is rolling out the Silkro RF Microneedling Platform with Plasma. Developed with the South Korean Intelligent Design Team and Research and Developer HIRONIC, this platform includes four handpieces: Silk RF MN, Silkro Plasma, Silkro Smooth, Silkro Precision, and Silkro Gentle.
- Potential of Epigenetic Reprogramming to Rejuvenate Skin Highlighted at SEASON Aesthetic Conference 2023https://modernaesthetics.com/news/potential-of-epigenetic-reprogramming-to-rejuvenate-skin-highlighted-at-season-aesthetic-conference-2023/2473408/Data supporting the potential of epigenetic reprogramming to rejuvenate skin was presented at S
- TAKE 5 WITH PETER KANG, CEO, COOLHEALTHhttps://modernaesthetics.com/news/take-5-with-peter-kang-ceo-coolhealth/2473406/Peter Kang, CEO of CoolHealth, chatted with Modern Aesthetics® magazine about the company and their first launch. TargetCool, a cooling device that takes cooling to the next level, provides temporary analgesia to the skin before aesthetic injections including fillers, neuromodulators, and pla